Moreover, depending on whether the tissue secretes IL-12 or TGF-β, FoxP3+ Tregs could be either immune suppression–competent or –incompetent, which strongly modifies the reaction of FoxP3+ Tregs to HNSCC and consequently the patient’s prognosis [34]. The gene discussed is FOXP3; the disease is head and neck squamous cell carcinoma.